Real-time enrollment status for this blood cancer clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 2:01 PM UTC
| NCT Number | NCT04068597 |
| Recruiting Status | Recruiting |
| Condition | Blood Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 250 participants |
| Active Locations | 6 sites in the US |
| Sponsor | CellCentric Ltd. |
| Last Updated on CT.gov | December 18, 2025 (Dec 18, 2025) |
As of March 2, 2026: Clinical trial NCT04068597 is currently recruiting participants. This clinical trial study for blood cancer is actively seeking new participants at 6 locations across the United States. The study is sponsored by CellCentric Ltd.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04068597 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 6 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04068597 was last updated Dec 18, 2025 (December 18, 2025). HelloStudys verifies this status automatically.